search
Back to results

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Primary Purpose

Head Trauma

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Docosahexaenoic Acid (DHA)
Sponsored by
Texas Christian University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Head Trauma

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Canadian national rugby athletes on 7s and 15s teams

Exclusion Criteria:

  • None

Sites / Locations

  • Texas Christian Universti

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Dietary Supplement

No Intervention

Arm Description

Docosahexaenoic Acid (DHA)

No Docosahexaenoic Acid supplementation

Outcomes

Primary Outcome Measures

Blood concentration of neurofilament light protein
Concentrations of neuronally derived proteins measured in blood

Secondary Outcome Measures

Full Information

First Posted
June 27, 2018
Last Updated
September 12, 2019
Sponsor
Texas Christian University
search

1. Study Identification

Unique Protocol Identification Number
NCT03582267
Brief Title
The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
Official Title
The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
August 1, 2017 (Actual)
Primary Completion Date
August 1, 2018 (Actual)
Study Completion Date
August 1, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Texas Christian University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Nutrition interventions may present a safe and relatively risk free intervention for protection against subconcussive impacts. Docosahexaenoic acid (DHA, 22:6n-3) is the principal Omega 3 polyunsaturated fatty acid in the brain, playing an integral role in the brain's development and structural integrity. The goal of this study is to determine if supplementation with DHA attenuates blood biomarkers of repetitive head trauma linked to sub-concussive impacts sustained in rugby participation.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Head Trauma

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
50 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Dietary Supplement
Arm Type
Experimental
Arm Description
Docosahexaenoic Acid (DHA)
Arm Title
No Intervention
Arm Type
No Intervention
Arm Description
No Docosahexaenoic Acid supplementation
Intervention Type
Dietary Supplement
Intervention Name(s)
Docosahexaenoic Acid (DHA)
Other Intervention Name(s)
Brain Armor DHA Liquid Concentrate
Intervention Description
Daily administration of docosahexaenoic Acid (DHA). 2 grams of DHA liquid concentrate administered per day throughout trial period.
Primary Outcome Measure Information:
Title
Blood concentration of neurofilament light protein
Description
Concentrations of neuronally derived proteins measured in blood
Time Frame
12 times throughout course of 1 year

10. Eligibility

Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Canadian national rugby athletes on 7s and 15s teams Exclusion Criteria: None
Facility Information:
Facility Name
Texas Christian Universti
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76129
Country
United States

12. IPD Sharing Statement

Learn more about this trial

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

We'll reach out to this number within 24 hrs